Doxofylline is not just another theophylline!

References

• WeinbergerMHendelesLTheophylline in asthmaN Engl J Med199633421138013888614425
   PubMed Web of Science ®Google Scholar
• HorakFDobererDEberEDiagnosis and management of asthma – Statement on the 2015 GINA GuidelinesWien Klin Wochenschr201612815–1654155427370268
   PubMed Web of Science ®Google Scholar
• VogelmeierCFCrinerGJMartínezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summaryAm J Respir Crit Care Med2017195555758228128970
   PubMed Web of Science ®Google Scholar
• HoritaNMiyazawaNKojimaRInoueMIshigatsuboYKanekoTChronic use of theophylline and mortality in chronic obstructive pulmonary disease: a Meta-analysisArch Bronconeumol201652523323826612542
   PubMed Web of Science ®Google Scholar
• SpinaDPageCPXanthines and phosphodiesterase inhibitorsHandb Exp Pharmacol2017237639127844172
   PubMedGoogle Scholar
• BarnesPJTheophyllineAm J Respir Crit Care Med201318890190623672674
   PubMed Web of Science ®Google Scholar
• ItoKLimSCaramoriGA molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expressionProc Natl Acad Sci U S A2002998921892612070353
   PubMed Web of Science ®Google Scholar
• UrnovFDWolffeAPChromatin remodeling and transcriptional activation: the cast (in order of appearance)Oncogene2001202991300611420714
   PubMed Web of Science ®Google Scholar
• ChapmanKRLjungholmKKallenALong-term xanthine therapy of asthma. Enprofylline and theophylline comparedChest1994106140714137956392
   PubMed Web of Science ®Google Scholar
• BarnesPJTheophylline: new perspectives for an old drugAm J Respir Crit Care Med200316781381812623857
   PubMed Web of Science ®Google Scholar
• HaskóGPacherPA2A receptors in inflammation and injury: lessons learned from transgenic animalsJ Leukoc Biol200883344745518160539
   PubMed Web of Science ®Google Scholar
• ToYItoKKizawaYTargeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201018289790420224070
   PubMed Web of Science ®Google Scholar
• FordPADurhamALRussellREGordonFAdcockIMBarnesPJTreatment effects of low dose theophylline combined with an inhaled corticosteroid in COPDChest20101371338134420299628
   PubMed Web of Science ®Google Scholar
• PerssonCGDevelopment of safer xanthine drugs for the treatment of obstructive airways diseaseJ Allergy Clin Immunol1986784 Pt 28178243534062
   PubMed Web of Science ®Google Scholar
• FozardJRHannonJPAdenosine receptor ligands: potential as therapeutic agents in asthma and COPDPulm Pharmacol Ther199912211111410373392
   PubMed Web of Science ®Google Scholar
• AbbracchioMPCattabeniFSelective activity of bamifylline on adenosine A1-receptors in rat brainPharmacol Res Commun19871985375453432321
   PubMedGoogle Scholar
• Boswell-SmithVPageCPRoflumilast: a phosphodiesterase-4 inhibitor for the treatment of respiratory diseaseExpert Opin Investig Drugs200615911051113
   PubMed Web of Science ®Google Scholar
• CalzettaLPageCPSpinaDEffect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle toneJ Pharmacol Exp Ther2013346341442323766543
   PubMed Web of Science ®Google Scholar
• PageCPDoxofylline: a “novofylline”Pulm Pharmacol Ther201023423123420380886
   PubMed Web of Science ®Google Scholar
• van MastbergenJJolasTAllegraLPageCPThe mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonismPulm Pharmacol Ther2012251556122138191
   PubMed Web of Science ®Google Scholar
• DiniFLCogoRDoxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effectsCurr Med Res Opin200116425826811268710
   PubMed Web of Science ®Google Scholar
• GoldsteinMFChervinskyPEfficacy and safety of doxofylline compared to theophylline in chronic reversible asthma – a double-blind randomized placebo-controlled multicentre clinical trialMed Sci Monit200284CR297CR30411951074
   PubMedGoogle Scholar
• FranzoneJSCirilloRBaroneDDoxofylline and theophylline are xanthines with partly different mechanisms of action in animalsDrugs Exp Clin Res19881474794893240706
   PubMedGoogle Scholar
• CirilloRGrossiEFranzoneJSDoxofylline, an adenosine-nonblocking xanthine, does not induce cardiostimulant effectsRes Commun Chem Pathol Pharmacol198965121342781149
   PubMedGoogle Scholar
• ZhangYZengKWangJGaoHNanYZhengXIdentifying the antiasthmatic target of doxofylline using immobilized β2-adrenoceptor based high-performance affinity chromatography and site-directed molecular dockingJ Mol Recognit2016291049249827173639
   PubMed Web of Science ®Google Scholar
• PatelBSKugelMJBaehringGAmmitAJDoxofylline does not increase formoterol-induced cAMP nor MKP-1 expression in ASM cells resulting in lack of anti-inflammatory effectPulm Pharmacol Ther201745343928414142
   PubMed Web of Science ®Google Scholar
• ZhouBCaiSXZouFCaiCQZhaoHJEffect of doxofylline on calcium-activated potassium channels in human peripheral blood eosinophils in asthmaZhonghua Jie He He Hu Xi Za Zhi20052812817819 Chinese16409781
   PubMedGoogle Scholar
• FranzoneJSCirilloRReboaniMCDoxofylline differs from methylxanthines in its movement of cytosolic calciumInt J Tissue React19911331311381960014
   PubMedGoogle Scholar
• FranzoneJSCirilloRBiffignandiPDoxofylline exerts a prophylactic effect against bronchoconstriction and pleurisy induced by PAFEur J Pharmacol19891652–32692772776832
   PubMed Web of Science ®Google Scholar
• Riffo-VasquezYManFPageCPDoxofylline, a novofylline inhibits lung inflammation induced by lipopolysacharide in the mousePulm Pharmacol Ther201427217017824456641
   PubMed Web of Science ®Google Scholar
• CogoRCastronuovoAEffects of oral doxofylline on inflammatory changes and altered cell proliferation in chronic obstructive bronchitisEur Rev Med Pharmacol Sci20004152011409184
   PubMedGoogle Scholar
• Riffo-VasquezYVenkatasamyRPageCPSteroid sparing effect of doxofyllinePulm Pharmacol Ther20184814
   PubMed Web of Science ®Google Scholar
• SugetaAImaiTIdairaSHirokoshiMOkamotoMAdachiMEffects of theophylline and doxofylline on airway responsiveness in dogsArerugi1997461715 Japanese9078607
   PubMedGoogle Scholar
• CravanzolaCGrosaGFranzoneJSKinetic and metabolic studies of 7-(1,3-dithiolan-2-ylmethyl)−1,3-dimethylxanthine in the ratDrugs Exp Clin Res19901662852912086163
   PubMedGoogle Scholar
• FranzoneJSCirilloRReboaniMCPharmacological studies in animals of beta-hydroxyethyltheophylline, the major metabolite of doxofylline in humansMethods Find Exp Clin Pharmacol19911342892991652045
   PubMedGoogle Scholar
• GrossiEFranzoneISFarmacocinetica clinica della doxofillina. [Doxofillin Clinical Pharmacokinetics]Farmaci198812119133 Italian
   Google Scholar
• BolognaELaganàATerracinoDBolignariPBiffignandiPOral and intravenous pharmacokinetic profiles of doxofylline in patients with chronic bronchitisJ Int Med Res19901842822882227075
   PubMed Web of Science ®Google Scholar
• JianGChunyanZZhaolongCYuzhenLErzhangCThe pharmacokinetics of doxofylline in ChineseChin J New Drugs20006396398
   Google Scholar
• GannuRBandariSSudkeSGRaoYMShankaBPDevelopment and validation of a stability-indicating RP-HPLC method for analysis of doxofylline in human serum. Application of the method to a pharmacokinetic studyActa Chromatographica200719149160
   Web of Science ®Google Scholar
• LeeJHNamgungHWKwonSYYoonHILeeCTThe pharmacokinetic profiles of oral doxofylline and factors influencing the serum level [abstract]Eur Respir J201138Suppl 55350s
   Google Scholar
• MenniniFSSciattellaPMarcellusiAMarcobelliARussoACaputiAPTreatment plan comparison in acute and chronic respiratory tract diseases: an observational study of doxophylline vs theophyllineExpert Rev Pharmacoecon Outcomes Res201717550351028277853
   PubMed Web of Science ®Google Scholar
• ShuklaDChakrabortySSinghSMishraBDoxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary diseaseExpert Opin Pharmacother200910142343235619678793
   PubMed Web of Science ®Google Scholar
• LazzaroniMGrossiEBianchi PorroGThe effect of intravenous doxofylline or aminophylline on gastric secretion in duodenal ulcer patientsAliment Pharmacol Therap1990466436492129651
   PubMed Web of Science ®Google Scholar
• SaccoCBarthiroliAGrossEDonnerCFThe effects of doxofylline vs theophylline on sleep architecture in COPD patientsMonaldi Arch Chest Dis1995502981037613555
   PubMedGoogle Scholar
• MargaySMFarhatSKaurSTeliHATo study the efficacy and safety of doxophylline and theophylline in bronchial asthmaJ Clin Diagn Res201594FC05FC08
   Google Scholar
• LalDManochaSRayAVijayanVKKumarRComparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary diseaseJ Basic Clin Physiol Pharmacol201526544345125894641
   PubMedGoogle Scholar
• AkramMFNasiruddinMAhmadZAli KhanRDoxofylline and theophylline: a comparative clinical studyJ Clin Diagn Res20126101681168423373027
   PubMedGoogle Scholar
• NagawaramPRKanchanpallyVComparative study of theophylline and doxofylline in the treatment of stable chronic obstructive pulmonary diseaseInt J Basic Clin Pharmacol201652251256
   Google Scholar
• RoglianiPCalzettaLCoppolaAOptimizing drug delivery in COPD: the role of inhaler devicesRespir Med201712461428284323
   PubMed Web of Science ®Google Scholar
• RoglianiPOraJPuxedduEMateraMGCazzolaMAdherence to COPD treatment: Myth and realityRespir Med201712911712328732818
   PubMed Web of Science ®Google Scholar